Saturday 17 October 2026
Export BHST’s income statement to Excel — free account
BioHarvest Sciences Inc.
BHST Consumer Defensive Packaged Foods
BioHarvest Sciences Inc.’s revenue for fiscal 2025 (year ended December 2025) was $34.5 million, up 37.0% from fiscal 2024. In the quarter to June 2026, revenue grew 3.78%, EPS grew 29.2%, free cash flow fell 64.0% and total debt fell 73.3%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
1.85
0.15
+8.82%
Follow BHST
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 4 | 4 | 5 |
| (200.22%) | (83.17%) | (103.29%) | (142.50%) | ||
| (38.97%) | (30.65%) | (31.71%) | (30.60%) | ||
ROIC |
(136.54%) | (69.80%) | (66.19%) | (64.30%) | |
Return on Tangible Assets |
(92.20%) | (35.76%) | (41.91%) | (47.22%) | |
Average Days of Receivables |
27.21 | 30.84 | 33.03 | 42.98 | |
Free Cash Flow per Share |
(0.54) | (0.52) | (0.42) | (0.47) | |
Free Cash Flow |
(9.46) | (9.58) | (9.44) | (10.75) | |
Capital Expenditures |
(2.09) | (2.35) | (2.26) | (2.24) | |
| Other line items | |||||
Cash ROIC |
(38.22%) | (18.77%) | (20.66%) | (27.82%) | |
Accounts Receivable Turnover |
14.66 | 14.60 | 12.99 | 10.67 | |
Accounts Payable Turnover |
3.37 | 4.56 | 4.44 | 4.72 | |
Inventory Turnover |
3.50 | 3.42 | 3.17 | 2.94 | |
Average Days of Payables |
95.31 | 68.33 | 68.76 | 68.85 | |
Days of Inventory on Hand |
121.27 | 118.59 | 127.44 | 144.84 | |
Tax Rate |
0.00 | 0.01 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
16.54% | 15.39% | 15.53% | 16.31% | |
Selling, General and Administrative Expense of Revenue |
61.44% | 60.10% | 60.15% | 60.63% | |
Share Based Compensation of Revenue |
1.82% | 1.73% | 1.94% | 2.69% | |
Interest Coverage |
(1.49) | (1.01) | (0.98) | (1.31) | |
Operating CF/Net income |
0.62 | 0.65 | 0.63 | 0.77 | |
Depreciation/Fixed assets |
0.19 | 0.20 | 0.19 | 0.19 | |
Capex/Depreciation |
(1.37) | (1.45) | (1.37) | (1.29) | |
Revenue per Share |
1.88 | 1.87 | 1.55 | 1.57 | |
Operating CF per Share |
(0.42) | (0.39) | (0.32) | (0.38) | |
Capex per Share |
(0.12) | (0.13) | (0.10) | (0.10) | |
Capex to Sales |
0.06 | 0.07 | 0.06 | 0.06 |
Columns are period end dates